First drug to prevent chronic migraines approved by EU

By: Press Association | First drug to prevent chronic migraines approved by EU | Neuroscience | The Guardian

Manufacturer says patients will be able to get treatment privately from September under EU licence

The first ever drug specifically designed to prevent a migraine has been given the green light by European health officials.

Erenumab is now expected to be considered by English and Scottish health agencies to assess whether it is appropriate for NHS use.

Continue reading…

icn-neurocience

Latest news and features from theguardian.com, the world’s leading liberal voice